Thanks for asking, which does bring us back to my original point, in trying to determine the risks of continually boosting yourself up with a jab that's known to elicit the spike protein. At the crux of that risk is how many times you continue to get jabbed up.
Early on there were medical professionals such as Peter McCullough who knew that it would be a leaky vaccine, and knew exactly why it would be. He was cast out as a "misinformationist" even though he's an expert in his field. The experts I listened to early on knew that it would mutate, and also knew that the mutations would be greater with a global mass vaccination campaign.
They are about to drop the mandate for them at my work, three years into the pandemic.
They'll be back, China is open.
I got it once, this past November. Felt shitty for about 5 days. No shots.
So the point is that vaccination is a useless tool vs. diseases and they should be let to run rampant till herd immunity is attained? Polio,Small Pox,even Measles were dealt w/successfully w/vac. campaigns. What about Covid's SARS cousins that didn't take hold and mutate,they are close cousins and should have behaved in a similar manner? The term "leaky" surmises that the developement of the Covid vaccine's aided and stimulated the mutant evolution of this virus,which vaccines?,all vaccines?,MNRA's or the many variants of old school tech vaccines based upon dead virus DNA or egg protein based.Seems like a vague claim,the array of vaccines developed are the equivalent of a 180 scientifically.
I was speaking specific to the modern covid jabs which were rushed to the market without the typical testing time-line. Other vaccines have other issues, but that is a topic for another thread. I'm not sure that covid jabs are a "useless tool", perhaps they may have some benefit to the elderly, but their benefit also has to be weighed against the fact that that same group will need covid jabs 3-times a year to maintain the benefit for which they seek (to help alleviate the symptoms associated with covid-19).
There’s also no “long flu”.
Good luck on trying to convince the anti-vaxxer's that long covid is actually a thing.
I was gonna toss off something indifferent, but their failure to grasp that their attitude is causing harm (and their misuse of anecdote as a premise) is an ongoing concern. People are (favorite insult here).
Are you certain that is the case? Just because something gets repeated ad nauseam does not make it true.
I noticed he hasn’t been around in a while too. Hope he’s ok but I suspect he’s not adjusting well to the stricter adherence to the TOS.
OK man,I see your point,desperate times call for desperate measures though,the mnra vaccines have been less effective than initially thought,I give you that and it does disappoint me that their endurance wanes. I do think mnra technology has a lot of potential as far as it's ability to be quickly tweaked and customized, making it a useful tool in the future of modern medicine, I hear a mnra influenza vaccine is being worked on which could aid in a better match seeing how the flu vaccine is developed based upon what happens in Australia and has been ineffective at times when the strain changed when it got to the US.
and? you can have it multiple times, you can have it, get over it, and get it again before you even know you're over the first case. some people gain strong immunity, and some do not. it also mutates quickly, and imminity to one strain is useless for any of the others...
Well the point about preventing infection is true,I've seen a guy at work who had 3 shots get Covid in August and again in December,I still believe they reduce severeness of symptoms pretty well,just reluctantly had to admit that they do not prevent infection as well as hoped if at all now due to mutation.Are you certain that is the case? Just because something gets repeated ad nauseam does not make it true.
Fact Check-Preventing transmission never required for COVID vaccines’ initial approval; Pfizer vax did reduce transmission of early variants
Social media users are circulating video clips of testimony by a Pfizer executive, who is said to “admit” that the company and its partner BioNTech did not test whether their mRNA-based COVID-19 vaccine reduced virus transmission prior to rolling it out – which is something...www.reuters.com
"At the time governments were negotiating advance purchases of vaccine in 2020, the European Medicines Agency had already laid out requirements for an application for conditional marketing authorization of a COVID-19 vaccine, clinical trials were underway, and tests to show the vaccine prevented onward transmission were not required of any vaccine maker.
In a presentation later that year (here), the EMA listed vaccine benefits that clinical trials were intended to demonstrate (slide 8 ), which included only safety and at least 50% efficacy against “symptomatic disease” (here).
The same presentation slide describes “Other benefits likely uncertain at approval and only clearer after the vaccine is used” to include the vaccine’s “long term protection,” “prevention of infection (asymptomatic cases),” and “prevention of virus transmission in the community - needs specific studies post-approval necessary to show.”
"A recent study in U.S. prisons, for example, found that vaccinated people who experience an Omicron breakthrough infection still have lower odds of passing the virus to their contacts (here). The protection was seen to start waning quickly, though, the journal Nature reported: “For every 5 weeks that passed since a person’s last vaccine dose, the risk of transmitting the infection to a close contact increased by 6%” (here)"
Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
COVID-19 vaccines are considered to have prevented an estimated tens of millions of SARS-CoV-2 infections and tens of thousands of COVID-19–related deaths in the US.1 However, the combination of reduced vaccine effectiveness against infection in the setting of Omicron sublineages and increased...jamanetwork.com
"Emerging new variants, including Omicron, are associated with less protection against infection. However, even modest protection against SARS-CoV-2 infection may provide important benefits by reducing surges that can overwhelm health care systems, keeping schools and workplaces open, and protecting vulnerable populations at risk for severe outcomes following infection, including older adults and those with underlying medical conditions.
"Second, prior infection was associated with a reduction in risk of infection and severe outcomes among those with or without prior vaccination. Additionally, among people with prior documented infection who had completed a primary vaccine series, booster vaccination was associated with additional protection, including 39.3% vaccine effectiveness against hospitalization after 3 months. Although prior infection alone is associated with lower risk of reinfection, vaccination also provides protection against ongoing transmission and has additional benefits, including attenuating severity of disease and reducing the risk of disabling postacute sequelae of COVID-19.9,14"
